About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 31–40 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 31 |
LANCET NEUROLOGY LANCET NEUROL |
1474-4422 1474-4465 |
45.5 | 56.2 | Q1 | 1/285 | ELSEVIER SCIENCE INC |
| 32 |
REVIEWS OF MODERN PHYSICS REV MOD PHYS |
0034-6861 1539-0756 |
44.8 | 56.3 | Q1 | 1/114 | AMER PHYSICAL SOC |
| 33 |
Nature Catalysis NAT CATAL |
2520-1158 2520-1158 |
44.6 | 47.4 | Q1 | 1/185 | NATURE PORTFOLIO |
| 34 |
CANCER CELL CANCER CELL |
1535-6108 1878-3686 |
44.5 | 47.2 | Q1 | 5/326 | CELL PRESS |
| 35 |
Nature Reviews Cardiology NAT REV CARDIOL |
1759-5002 1759-5010 |
44.2 | 52.9 | Q1 | 1/230 | NATURE PORTFOLIO |
| 36 |
BMJ-British Medical Journal BMJ-BRIT MED J |
0959-535X 1756-1833 |
42.7 | 76.1 | Q1 | 5/332 | BMJ PUBLISHING GROUP |
| 37 |
CELL CELL |
0092-8674 1097-4172 |
42.5 | 48.9 | Q1 | 3/319 | CELL PRESS |
| 38 |
JOURNAL OF CLINICAL ONCOLOGY J CLIN ONCOL |
0732-183X 1527-7755 |
41.9 | 37.7 | Q1 | 6/326 | LIPPINCOTT WILLIAMS & WILKINS |
| 39 |
Lancet Diabetes & Endocrinology LANCET DIABETES ENDO |
2213-8587 2213-8595 |
41.8 | 41.7 | Q1 | 1/191 | ELSEVIER SCIENCE INC |
| 40 |
NATURE BIOTECHNOLOGY NAT BIOTECHNOL |
1087-0156 1546-1696 |
41.7 | 59.5 | Q1 | 2/177 | NATURE PORTFOLIO |